These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 23662047)
1. Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial. Takami T; Saito Y Drug Des Devel Ther; 2013; 7():175-83. PubMed ID: 23662047 [TBL] [Abstract][Full Text] [Related]
2. Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study. Takami T; Saito Y Vasc Health Risk Manag; 2011; 7():383-90. PubMed ID: 21796252 [TBL] [Abstract][Full Text] [Related]
3. Impact of azelnidipine treatment on left ventricular diastolic performance in patients with hypertension and mild diastolic dysfunction: multi-center study with echocardiography. Ito H; Ishii K; Iwakura K; Nakamura F; Nagano T; Takiuchi S Hypertens Res; 2009 Oct; 32(10):895-900. PubMed ID: 19680260 [TBL] [Abstract][Full Text] [Related]
4. Impact of azelnidipine and amlodipine on left ventricular mass and longitudinal function in hypertensive patients with left ventricular hypertrophy. Motoki H; Koyama J; Izawa A; Tomita T; Miyashita Y; Takahashi M; Ikeda U Echocardiography; 2014 Nov; 31(10):1230-8. PubMed ID: 24645985 [TBL] [Abstract][Full Text] [Related]
5. Effects of combination therapy with olmesartan and azelnidipine on serum osteoprotegerin in patients with hypertension. Uzui H; Morishita T; Nakano A; Amaya N; Fukuoka Y; Ishida K; Arakawa K; Lee JD; Tada H J Cardiovasc Pharmacol Ther; 2014 May; 19(3):304-9. PubMed ID: 24288395 [TBL] [Abstract][Full Text] [Related]
6. Design and rationale of Japanese evaluation between Formula of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study (J-FLAG) : evaluation of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria. Ando K; Haneda M; Ito S; Kashihara N; Node K; Nangaku M; Shimosawa T; Kishimoto J; Fujita T Cardiovasc Drugs Ther; 2011 Aug; 25(4):341-7. PubMed ID: 21637969 [TBL] [Abstract][Full Text] [Related]
7. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study. Shimada K; Ogihara T; Saruta T; Kuramoto K; Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495 [TBL] [Abstract][Full Text] [Related]
8. Comparison of olmesartan medoxomil versus amlodipine besylate on regression of ventricular and vascular hypertrophy. Rosendorff C; Dubiel R; Xu J; Chavanu KJ Am J Cardiol; 2009 Aug; 104(3):359-65. PubMed ID: 19616668 [TBL] [Abstract][Full Text] [Related]
9. Changes in left ventricular relaxation after azelnidipine treatment in hypertensive patients with diabetes: subanalysis of a prospective single-arm multicentre study. Iwakura K; Ito H; Ishii K; Date M; Nakamura F; Nagano T; Takiuchi S; BMJ Open; 2014 Sep; 4(9):e006136. PubMed ID: 25270860 [TBL] [Abstract][Full Text] [Related]
10. [Effects of Amlodipine/Lisinopril Fixed-Dose Combination on Severity of Left Ventricular Hypertrophy and Parameters of Myocardial Stiffness in Patients With Hypertension]. Ostroumova OD; Kochetkov AI Kardiologiia; 2016 Dec; 56(11):27-37. PubMed ID: 28290816 [TBL] [Abstract][Full Text] [Related]
11. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study. Matsui Y; O'Rourke MF; Hoshide S; Ishikawa J; Shimada K; Kario K Hypertension; 2012 Jun; 59(6):1132-8. PubMed ID: 22547439 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of azelnidipine on home blood pressure and pulse rate in patients with essential hypertension: comparison with amlodipine. Yamagishi T Hypertens Res; 2006 Oct; 29(10):767-73. PubMed ID: 17283863 [TBL] [Abstract][Full Text] [Related]
13. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Matsui Y; Eguchi K; O'Rourke MF; Ishikawa J; Miyashita H; Shimada K; Kario K Hypertension; 2009 Oct; 54(4):716-23. PubMed ID: 19667251 [TBL] [Abstract][Full Text] [Related]
14. Effects of azelnidipine on the autonomic functions and its influence on arterial stiffness and endothelial functions. Yamada J; Tomiyama H; Matsumoto C; Yoshida M; Shiina K; Yamashina A J Cardiol; 2008 Apr; 51(2):114-20. PubMed ID: 18522784 [TBL] [Abstract][Full Text] [Related]
15. Association of changes in ambulatory arterial stiffness index and pulse wave velocity during antihypertensive treatment: the J-CORE study. Matsui Y; O'Rourke MF; Ishikawa J; Shimada K; Kario K Am J Hypertens; 2012 Aug; 25(8):862-8. PubMed ID: 22647783 [TBL] [Abstract][Full Text] [Related]
16. Azelnidipine and amlodipine: a comparison of their effects and safety in a randomized double-blinded clinical trial in Chinese essential hypertensive patients. Zhao X; Wu F; Jia S; Qu P; Li H; Zhao X; Cao B; Lin Y; Wang M Clin Exp Hypertens; 2010; 32(6):372-6. PubMed ID: 21029001 [TBL] [Abstract][Full Text] [Related]
17. Comparative Study of the Efficacy of Olmesartan/Amlodipine vs. Perindopril/Amlodipine in Peripheral and Central Blood Pressure Parameters After Missed Dose in Type 2 Diabetes. Redon J; Pichler G; Am J Hypertens; 2016 Sep; 29(9):1055-62. PubMed ID: 27220840 [TBL] [Abstract][Full Text] [Related]
18. Association between arterial stiffness and left ventricular diastolic function in relation to gender and age. Kim HL; Lim WH; Seo JB; Chung WY; Kim SH; Kim MA; Zo JH Medicine (Baltimore); 2017 Jan; 96(1):e5783. PubMed ID: 28072727 [TBL] [Abstract][Full Text] [Related]
19. The combination of OLmesartan and a CAlcium channel blocker (azelnidipine) or candesartan and a calcium channel blocker (amlodipine) in type 2 diabetic hypertensive patients: the OLCA study. Daikuhara H; Kikuchi F; Ishida T Diab Vasc Dis Res; 2012 Oct; 9(4):280-6. PubMed ID: 22718810 [TBL] [Abstract][Full Text] [Related]
20. Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study. Barrios V; Brommer P; Haag U; Calderón A; Escobar C Clin Drug Investig; 2009; 29(7):427-439. PubMed ID: 19499960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]